Drug trial GPs are set to lose £30k
Dr Barry Silvert is warning many GPs could lose £30,000 a year in clinical research contracts because primary care organisations are 'muscling in' on approval for drug trials.
Dr Silvert, chair of the British Association of Clinical Research in Primary Care, set up last month, said PCOs were adding extra bureaucracy to the approvals process. 'PCTs do not have a role in making decisions as to whether a trial is ethical or not,' he said.
'It's already cheaper for the pharmaceutical industry to work in eastern Europe and this could be the final straw.'
Around 700 GPs stood to lose between £20,000 to £30,000 a year if the trials went overseas, added Dr Silvert, a GP in Bolton.